Aktis Oncology AKTS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 114.78 | -18.17 | -17,375 | -15 | ||
| 2025Q3 | ||||||
| 2024Q4 | -15,635 | -12 | ||||
| 2024Q3 | 93.52 | -0.04 | -5,336 | -6 | ||
| 2024Q2 | 46.93 | -1.14 | -50,704 | -109 | ||
| 2024Q1 | 100.21 | -0.26 | -22,608 | -23 | ||
| 2023Q4 | 121.48 | -0.21 | -34,794 | -29 | ||
| 2023Q3 | 110.24 | -0.28 | -21,654 | -20 | ||
| 2023Q2 | 102.88 | -0.25 | -17,928 | -18 | ||
| 2023Q1 | 99.33 | -0.22 | -17,283 | -16 | ||
| 2022Q4 | 123.33 | -0.20 | -12,892 | -11 | ||
| 2022Q3 | 97.61 | -0.33 | -17,966 | -19 | ||
| 2022Q2 | 98.80 | -0.28 | -17,657 | -16 | ||
| 2022Q1 | 98.80 | -0.27 | -14,799 | -15 | ||
| 2021Q4 | -0.29 | -15,215 | -15 | |||
| 2021Q3 | -0.25 | -12,884 | -13 | |||
| 2021Q2 | 116.00 | -0.19 | -11,777 | -10 | ||
| 2021Q1 | 111.39 | -0.22 | -9,076 | -10 | ||
| 2020Q4 | 100.15 | -0.30 | -10,221 | -12 | ||
| 2020Q3 | 98.11 | -0.31 | -10,320 | -12 |